News Ionis Wins First-Ever FDA Approval for Alexander Disease with Zanvastro pharminent September 4, 2026
News Ivonescimab Beats Keytruda on Survival in China-Only Trial as Its Global Study Stumbles pharminent September 3, 2026
News UK Suspends Amgen’s Tavneos for New Patients as a Data-Integrity Cascade Spreads Across Three Regulators pharminent September 2, 2026
News Novartis Posts Phase 3 MS Win and Halts Eight Autoimmune CAR-T Trials pharminent September 1, 2026
News Lilly Pays Up to $2.875 Billion for Merida and a Phase 1 Autoantibody Platform pharminent August 31, 2026
News FDA Approves Mounjaro Label Expansion to Reduce Cardiovascular Risk in Type 2 Diabetes pharminent August 28, 2026
News FDA Approves Priovant’s LISRAYA (Brepocitinib), the First Targeted Therapy for Dermatomyositis pharminent August 28, 2026
News FDA Approves Revolution Medicines’ Rasonque, First RAS(ON) Inhibitor for Metastatic Pancreatic Cancer pharminent August 26, 2026
News FDA Approves J&J’s Imaavy for Warm Autoimmune Hemolytic Anemia, the First Therapy Ever Cleared in the Disease pharminent August 25, 2026
News Genentech Licenses Hanmi’s Muscle-Sparing Obesity Drug in Deal Worth Up to $2.3 Billion pharminent August 24, 2026
News Johnson & Johnson Wins EU Approval for Tecvayli-Daratumumab in Second-Line Myeloma pharminent August 21, 2026
News Regeneron’s Pasatru Wins Full FDA Approval for Ultra-Rare ‘Stone Man Disease’ pharminent August 20, 2026
News Moderna and Merck’s Personalized Melanoma Vaccine Scores Historic Phase 3 Win pharminent August 19, 2026
News Amylyx’s Avexitide Succeeds in Phase 3 Pivotal Study for Post-Bariatric Hypoglycemia pharminent August 18, 2026
News AstraZeneca Claims Dual Lung Cancer Phase 3 Wins, but Bispecific Failure Steals the Headline pharminent August 17, 2026
News BMS Wins First FDA Approval for CELMoD Class With Zenbexus in Multiple Myeloma pharminent August 14, 2026
News Eli Lilly Files Six Lawsuits to Combat Illegal Retatrutide Black Market pharminent August 12, 2026
News Trump Executive Order Strips Seven Vaccines From Childhood Immunization Recommendations pharminent August 11, 2026
News FDA Approves Moderna’s mFlusiva, the First mRNA-Based Seasonal Flu Vaccine pharminent August 6, 2026
News Eli Lilly Smashes Q2 Estimates, Raises 2026 Guidance to $85–$87B on GLP-1 Surge pharminent August 5, 2026
News Pfizer Axes Ex-Metsera Obesity Asset and GIPR Prospect in Quarterly Pipeline Clearout pharminent August 4, 2026
News AstraZeneca and Bristol Myers Squibb Reported to Have Held Mega-Merger Talks pharminent August 3, 2026
News Novo Nordisk’s Ziltivekimab Misses Primary Endpoint in Pivotal Cardiovascular Trial pharminent August 1, 2026
News Amgen’s Repatha Wins Positive CHMP Opinion for Preventing First Heart Attacks and Strokes pharminent July 30, 2026
News Vertex, AbCellera Partner on Next-Generation T-Cell Engagers for Autoimmune Disease pharminent July 29, 2026
News GSK Unveils Three-Year Restructuring to Fund Late-Stage R&D Ahead of Patent Cliff pharminent July 28, 2026
News AstraZeneca Says Drug Pricing Is ‘Evolving’ in Response to Trump’s Most-Favored-Nation Policy pharminent July 27, 2026
News EMA CHMP Recommends Twelve New Medicines for Approval at July 2026 Meeting pharminent July 24, 2026
News Lilly’s Retatrutide Hits 22.6% Weight Loss in Phase 3, But Cardiovascular Benefit Remains Elusive pharminent July 23, 2026
News Arrowhead’s Plozasiran Cuts Triglycerides Roughly 80% in Two Phase 3 Trials pharminent July 22, 2026
News Samsung Biologics Acquires Swiss CDMO PolyPeptide in $1.81bn All-Cash Deal pharminent July 20, 2026